Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients

Metabolism. 2020 Sep:110:154300. doi: 10.1016/j.metabol.2020.154300. Epub 2020 Jun 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Cytokines
  • Humans
  • Immunomodulation
  • Pandemics*
  • Phosphodiesterase 4 Inhibitors*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Cytokines
  • Phosphodiesterase 4 Inhibitors
  • Cyclic Nucleotide Phosphodiesterases, Type 4